Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
Leszek
Przemyslaw
P
Kruszewski
Marcin
M
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D000068256:Darbepoetin alfa; D004311:Double-Blind Method; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005290:Ferric Compounds / Q000008:administration & dosage*; D006333:Heart Failure / Q000188:drug therapy*; D006397:Hematinics / Q000008:administration & dosage*; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic
D005290:Ferric Compounds; D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa